Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis

AIM: This retrospective study aimed to evaluate the predictive value of serum cancer antigen 125 (CA125) levels before hormone replacement therapy on pregnancy outcomes in women with adenomyosis undergoing frozen embryo transfer. METHODS: A total of 509 women with adenomyosis were screened and 84 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ling, Li, Yubin, Chen, Minghui, Wang, Zengyan, Zhou, Canquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072100/
https://www.ncbi.nlm.nih.gov/pubmed/33887984
http://dx.doi.org/10.1177/03000605211005878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072100/
https://www.ncbi.nlm.nih.gov/pubmed/33887984
http://dx.doi.org/10.1177/03000605211005878

Ejemplares similares